$XBIT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in XBiotech Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in XBiotech Inc.. Get notifications about new insider transactions in XBiotech Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | XBIT | XBiotech Inc. | Libby Peter | Director | Option Exercise | A | 16.21 | 25,000 | 405,250 | 25,000 | |
| Jun 24 2021 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | A | 16.21 | 25,000 | 405,250 | 25,000 | |
| Apr 27 2021 | XBIT | XBiotech Inc. | Libby Peter | Director | Option Exercise | A | 18.25 | 25,000 | 456,250 | 25,000 | |
| Mar 22 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 7.50 | 500,000 | 3,750,000 | 0 | |
| Mar 22 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Buy | M | 7.50 | 500,000 | 3,750,000 | 4,223,166 | 3.7 M to 4.2 M (+13.43 %) |
| Feb 01 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | W | 11.12 | 500,000 | 5,560,000 | 500,000 | |
| Feb 01 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | W | 7.45 | 150,000 | 1,117,500 | 150,000 | |
| Feb 01 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | W | 4.44 | 89,260 | 396,314 | 110,740 | |
| Feb 01 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | W | 4.24 | 13,484 | 57,172 | 61,516 | |
| Feb 01 2021 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | W | 9.45 | 1,875 | 17,719 | 48,125 | |
| Dec 18 2020 | XBIT | XBiotech Inc. | BAY STREET FINANCIAL S.A. | 10% Owner | Sell | S | 18.78 | 1,173,033 | 22,029,560 | 1,981,515 | 3.2 M to 2 M (-37.19 %) |
| Dec 02 2020 | XBIT | XBiotech Inc. | BAY STREET FINANCIAL S.A. | 10% Owner | Sell | S | 18.42 | 182,836 | 3,367,839 | 3,154,548 | 3.3 M to 3.2 M (-5.48 %) |
| Sep 21 2020 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Sell | J | 0.00 | 500,000 | 0 | 3,723,166 | 4.2 M to 3.7 M (-11.84 %) |
| Sep 16 2020 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Option Exercise | M | 7.50 | 20,668 | 155,010 | 0 | |
| Sep 16 2020 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Option Exercise | M | 7.50 | 19,332 | 144,990 | 0 | |
| Sep 16 2020 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Sell | S | 20.00 | 20,668 | 413,360 | 0 | 20.7 K to 0 (-100.00 %) |
| Sep 16 2020 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Buy | M | 7.50 | 20,668 | 155,010 | 20,668 | 0 to 20.7 K |
| Sep 16 2020 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Sell | S | 20.01 | 19,332 | 386,833 | 0 | 19.3 K to 0 (-100.00 %) |
| Sep 16 2020 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Buy | M | 7.50 | 19,332 | 144,990 | 19,332 | 0 to 19.3 K |
| Sep 02 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 4.16 | 27,692 | 115,199 | 0 | |
| Sep 02 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 4.24 | 30,000 | 127,200 | 0 | |
| Sep 02 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 4.16 | 27,692 | 115,199 | 57,692 | 30 K to 57.7 K (+92.31 %) |
| Sep 02 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 4.24 | 30,000 | 127,200 | 30,000 | 0 to 30 K |
| Sep 01 2020 | XBIT | XBiotech Inc. | Waldin Jan-Paul | Director | Option Exercise | A | 18.25 | 25,000 | 456,250 | 25,000 | |
| Sep 01 2020 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | A | 18.25 | 25,000 | 456,250 | 25,000 | |
| Sep 01 2020 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | A | 18.25 | 25,000 | 456,250 | 25,000 | |
| Sep 01 2020 | XBIT | XBiotech Inc. | MacAdam Donald H. | Director | Option Exercise | A | 18.25 | 25,000 | 456,250 | 25,000 | |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 5.26 | 12,500 | 65,750 | 0 | |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 4.14 | 3,333 | 13,799 | 0 | |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 4.16 | 12,308 | 51,201 | 0 | |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 15.00 | 5,000 | 75,000 | 0 | |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 7.50 | 18,700 | 140,250 | 0 | |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 19.65 | 12,500 | 245,679 | 0 | 12.5 K to 0 (-100.00 %) |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 5.26 | 12,500 | 65,750 | 12,500 | 0 to 12.5 K |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 19.65 | 3,333 | 65,508 | 0 | 3.3 K to 0 (-100.00 %) |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 4.14 | 3,333 | 13,799 | 3,333 | 0 to 3.3 K |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 19.65 | 12,308 | 241,905 | 0 | 12.3 K to 0 (-100.00 %) |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 4.16 | 12,308 | 51,201 | 12,308 | 0 to 12.3 K |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 19.65 | 5,000 | 98,272 | 0 | 5 K to 0 (-100.00 %) |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 15.00 | 5,000 | 75,000 | 5,000 | 0 to 5 K |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 19.65 | 18,700 | 367,535 | 0 | 18.7 K to 0 (-100.00 %) |
| Aug 26 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 7.50 | 18,700 | 140,250 | 18,700 | 0 to 18.7 K |
| Aug 21 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 7.50 | 1,300 | 9,750 | 0 | |
| Aug 21 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 19.30 | 1,300 | 25,090 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 21 2020 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 7.50 | 1,300 | 9,750 | 1,300 | 0 to 1.3 K |
| Mar 25 2020 | XBIT | XBiotech Inc. | BAY STREET FINANCIAL S.A. | 10% Owner | Sell | S | 6.38 | 1,662,616 | 10,607,490 | 3,337,384 | 5 M to 3.3 M (-33.25 %) |
| Feb 14 2020 | XBIT | XBiotech Inc. | GUT THOMAS | 10% Owner | Sell | D | 30.00 | 1,868,870 | 56,066,100 | 3,995,170 | 5.9 M to 4 M (-31.87 %) |
| Feb 13 2020 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Gift | G | 0.00 | 5,000,000 | 0 | 110,282 | 5.1 M to 110.3 K (-97.84 %) |
| Feb 13 2020 | XBIT | XBiotech Inc. | Waldin Jan-Paul | Director | Sell | D | 30.00 | 95,612 | 2,868,360 | 204,388 | 300 K to 204.4 K (-31.87 %) |
| Feb 13 2020 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Sell | D | 30.00 | 2,016,466 | 60,493,980 | 4,310,594 | 6.3 M to 4.3 M (-31.87 %) |
| Jan 09 2020 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | M | 3.75 | 46,000 | 172,500 | 1,199,500 | |
| Jan 09 2020 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | M | 3.75 | 77,000 | 288,750 | 1,245,500 | |
| Jan 09 2020 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | M | 3.75 | 123,000 | 461,250 | 3,706,600 | 3.6 M to 3.7 M (+3.43 %) |
| Dec 11 2019 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 11.12 | 1,000,000 | 11,120,000 | 2,625,000 | |
| Dec 11 2019 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 11.12 | 1,000,000 | 11,120,000 | 2,625,000 | |
| Dec 04 2019 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | M | 3.75 | 185,000 | 693,750 | 0 | |
| Dec 04 2019 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | M | 3.75 | 185,000 | 693,750 | 3,583,600 | 3.4 M to 3.6 M (+5.44 %) |
| Nov 08 2019 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | A | 10.36 | 75,000 | 777,000 | 75,000 | |
| Nov 08 2019 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Option Exercise | M | 10.36 | 100,000 | 1,036,000 | 100,000 | |
| Sep 09 2019 | XBIT | XBiotech Inc. | Libby Peter | Director | Option Exercise | A | 7.76 | 25,000 | 194,000 | 25,000 | |
| Jul 01 2019 | XBIT | XBiotech Inc. | Waldin Jan-Paul | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
| Jul 01 2019 | XBIT | XBiotech Inc. | Waldin Jan-Paul | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
| Jul 01 2019 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
| Jul 01 2019 | XBIT | XBiotech Inc. | MacAdam Donald H. | Director | Option Exercise | A | 7.45 | 25,000 | 186,250 | 25,000 | |
| Jun 28 2019 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 7.45 | 300,000 | 2,235,000 | 300,000 | |
| Jun 06 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 8.25 | 1,200,000 | 9,900,000 | 5,110,282 | 3.9 M to 5.1 M (+30.69 %) |
| Mar 05 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 7.91 | 16,426 | 129,930 | 3,910,282 | 3.9 M to 3.9 M (+0.42 %) |
| Mar 04 2019 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Option Exercise | A | 5.26 | 15,000 | 78,900 | 15,000 | |
| Mar 04 2019 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Option Exercise | M | 2.50 | 4,500 | 11,250 | 0 | |
| Mar 04 2019 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Sell | S | 10.00 | 4,500 | 45,000 | 0 | 4.5 K to 0 (-100.00 %) |
| Mar 04 2019 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Buy | M | 2.50 | 4,500 | 11,250 | 4,500 | 0 to 4.5 K |
| Mar 04 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 8.13 | 34,999 | 284,542 | 3,893,856 | 3.9 M to 3.9 M (+0.91 %) |
| Mar 04 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 8.19 | 5,302 | 43,423 | 3,858,857 | 3.9 M to 3.9 M (+0.14 %) |
| Mar 04 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 8.13 | 5,273 | 42,869 | 3,853,555 | 3.8 M to 3.9 M (+0.14 %) |
| Feb 14 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 10.00 | 40,000 | 400,000 | 3,698,282 | 3.7 M to 3.7 M (+1.09 %) |
| Feb 14 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 9.49 | 30,000 | 284,700 | 3,658,282 | 3.6 M to 3.7 M (+0.83 %) |
| Feb 14 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 8.93 | 35,000 | 312,550 | 3,628,282 | 3.6 M to 3.6 M (+0.97 %) |
| Feb 14 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 5.15 | 900 | 4,635 | 3,593,282 | 3.6 M to 3.6 M (+0.03 %) |
| Feb 14 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 4.98 | 2,200 | 10,956 | 3,592,382 | 3.6 M to 3.6 M (+0.06 %) |
| Feb 14 2019 | XBIT | XBiotech Inc. | RENNES FONDATION | 10% Owner | Buy | P | 6.24 | 4,200 | 26,208 | 3,590,182 | 3.6 M to 3.6 M (+0.12 %) |
| Dec 28 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 4.92 | 1,364 | 6,706 | 32,702 | 31.3 K to 32.7 K (+4.35 %) |
| Dec 28 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 5.00 | 3,600 | 17,996 | 31,338 | 27.7 K to 31.3 K (+12.98 %) |
| Dec 28 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 5.88 | 24,838 | 146,097 | 27,738 | 2.9 K to 27.7 K (+856.48 %) |
| Dec 20 2018 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 2.50 | 50,000 | 125,000 | 0 | |
| Dec 20 2018 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Buy | M | 2.50 | 50,000 | 125,000 | 6,327,060 | 6.3 M to 6.3 M (+0.80 %) |
| Nov 13 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 3.75 | 700 | 2,625 | 2,900 | 2.2 K to 2.9 K (+31.82 %) |
| Nov 13 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 3.74 | 2,200 | 8,217 | 2,200 | 0 to 2.2 K |
| Nov 13 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 3.75 | 700 | 2,625 | 2,900 | 2.2 K to 2.9 K (+31.82 %) |
| Nov 13 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Buy | P | 3.74 | 2,200 | 8,217 | 2,200 | 0 to 2.2 K |
| Oct 12 2018 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | A | 4.26 | 15,000 | 63,900 | 15,000 | |
| Oct 04 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.00 | 385,000 | 1,155,000 | 3,398,600 | 3.8 M to 3.4 M (-10.18 %) |
| Oct 01 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.05 | 17,634 | 53,798 | 3,783,600 | 3.8 M to 3.8 M (-0.46 %) |
| Sep 18 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.10 | 7,909 | 24,549 | 3,801,234 | 3.8 M to 3.8 M (-0.21 %) |
| Sep 18 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.06 | 41,675 | 127,546 | 3,809,143 | 3.9 M to 3.8 M (-1.08 %) |
| Sep 11 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.22 | 23,369 | 75,335 | 3,850,818 | 3.9 M to 3.9 M (-0.60 %) |
| Sep 11 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.65 | 6,234 | 22,763 | 3,874,187 | 3.9 M to 3.9 M (-0.16 %) |
| Sep 06 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.69 | 7,159 | 26,397 | 3,880,421 | 3.9 M to 3.9 M (-0.18 %) |
| Sep 06 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.94 | 7,220 | 28,481 | 3,887,580 | 3.9 M to 3.9 M (-0.19 %) |
| Sep 06 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.99 | 3,800 | 15,179 | 3,894,800 | 3.9 M to 3.9 M (-0.10 %) |
| Aug 13 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.98 | 3,171 | 12,623 | 0 | 3.2 K to 0 (-100.00 %) |
| Aug 13 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 4.00 | 6,638 | 26,523 | 3,171 | 9.8 K to 3.2 K (-67.67 %) |
| Aug 08 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 4.01 | 4,000 | 16,024 | 121,309 | 125.3 K to 121.3 K (-3.19 %) |
| Aug 08 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.94 | 8,452 | 33,332 | 125,309 | 133.8 K to 125.3 K (-6.32 %) |
| Aug 08 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.99 | 3,340 | 13,328 | 133,761 | 137.1 K to 133.8 K (-2.44 %) |
| Aug 08 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 4.01 | 4,000 | 16,024 | 121,309 | 125.3 K to 121.3 K (-3.19 %) |
| Aug 08 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.94 | 8,452 | 33,332 | 125,309 | 133.8 K to 125.3 K (-6.32 %) |
| Aug 08 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.99 | 3,340 | 13,328 | 133,761 | 137.1 K to 133.8 K (-2.44 %) |
| Aug 03 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.96 | 23,900 | 94,689 | 25,601 | 49.5 K to 25.6 K (-48.28 %) |
| Aug 03 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 3.92 | 30,461 | 119,529 | 49,501 | 80 K to 49.5 K (-38.09 %) |
| Aug 03 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 4.24 | 8,163 | 34,649 | 79,962 | 88.1 K to 80 K (-9.26 %) |
| Aug 01 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 4.49 | 6,531 | 29,320 | 88,125 | 94.7 K to 88.1 K (-6.90 %) |
| Aug 01 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Sell | S | 4.41 | 5,344 | 23,542 | 94,656 | 100 K to 94.7 K (-5.34 %) |
| Jun 21 2018 | XBIT | XBiotech Inc. | Waldin Jan-Paul | Director | Option Exercise | A | 4.44 | 12,500 | 55,500 | 12,500 | |
| Jun 21 2018 | XBIT | XBiotech Inc. | MacAdam Donald H. | Director | Option Exercise | A | 4.44 | 12,500 | 55,500 | 12,500 | |
| Jun 21 2018 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | A | 4.44 | 25,000 | 111,000 | 25,000 | |
| Jun 21 2018 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | A | 4.44 | 200,000 | 888,000 | 200,000 | |
| May 11 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 4.16 | 40,000 | 166,400 | 40,000 | |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 2.50 | 8,201 | 20,503 | 0 | |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 2.50 | 62,200 | 155,500 | 0 | |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 2.50 | 9,599 | 23,998 | 0 | |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 4.75 | 8,201 | 38,955 | 0 | 8.2 K to 0 (-100.00 %) |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 2.50 | 8,201 | 20,503 | 8,201 | 0 to 8.2 K |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 4.76 | 62,200 | 296,159 | 0 | 62.2 K to 0 (-100.00 %) |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 2.50 | 62,200 | 155,500 | 62,200 | 0 to 62.2 K |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 4.48 | 9,599 | 42,987 | 0 | 9.6 K to 0 (-100.00 %) |
| Mar 26 2018 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 2.50 | 9,599 | 23,998 | 9,599 | 0 to 9.6 K |
| Mar 22 2018 | XBIT | XBiotech Inc. | MacAdam Donald H. | Director | Option Exercise | A | 4.78 | 25,000 | 119,500 | 25,000 | |
| Nov 22 2017 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | Chief Scientific Of ... | Option Exercise | A | 4.13 | 150,000 | 619,500 | 150,000 | |
| Jul 11 2017 | XBIT | XBiotech Inc. | Guzman Benjamin | Sr.VP Corp. Strateg ... | Option Exercise | A | 4.78 | 300,000 | 1,434,000 | 300,000 | |
| Jun 26 2017 | XBIT | XBiotech Inc. | VASELLA DANIEL | Director | Option Exercise | M | 4.24 | 50,000 | 212,000 | 50,000 | |
| Jun 23 2017 | XBIT | XBiotech Inc. | BONANNI FABRIZIO | Director | Option Exercise | M | 4.24 | 50,000 | 212,000 | 50,000 | |
| Jun 23 2017 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | M | 4.24 | 50,000 | 212,000 | 50,000 | |
| Jun 23 2017 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 4.24 | 75,000 | 318,000 | 75,000 | |
| Jun 23 2017 | XBIT | XBiotech Inc. | SHIVASWAMY SUSHMA | VP Research and Dev ... | Option Exercise | M | 4.24 | 50,000 | 212,000 | 50,000 | |
| Jun 23 2017 | XBIT | XBiotech Inc. | STECHER MICHAEL | Medical Director | Option Exercise | M | 4.24 | 50,000 | 212,000 | 50,000 | |
| Jun 23 2017 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 4.24 | 30,000 | 127,200 | 50,000 | |
| May 25 2017 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Option Exercise | M | 0.93 | 240,000 | 223,608 | 0 | |
| May 25 2017 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Payment of Exercise | F | 8.17 | 116,207 | 949,411 | 6,277,060 | 6.4 M to 6.3 M (-1.82 %) |
| May 25 2017 | XBIT | XBiotech Inc. | SIMARD JOHN | Chief Executive Off ... | Buy | M | 0.93 | 240,000 | 223,608 | 6,393,267 | 6.2 M to 6.4 M (+3.90 %) |
| Dec 08 2016 | XBIT | XBiotech Inc. | VASELLA DANIEL | Director | Option Exercise | A | 15.00 | 125,000 | 1,875,000 | 125,000 | |
| Dec 08 2016 | XBIT | XBiotech Inc. | VASELLA DANIEL | Director | Option Exercise | D | 15.00 | 125,000 | 1,875,000 | 0 | |
| Dec 08 2016 | XBIT | XBiotech Inc. | VASELLA DANIEL | Director | Option Exercise | A | 13.27 | 23,867 | 316,715 | 23,867 | |
| Nov 17 2016 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 0.74 | 19,573 | 14,484 | 0 | |
| Nov 17 2016 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 15.00 | 19,573 | 293,595 | 0 | 19.6 K to 0 (-100.00 %) |
| Nov 17 2016 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Buy | M | 0.74 | 19,573 | 14,484 | 19,573 | 0 to 19.6 K |
| Sep 16 2016 | XBIT | XBiotech Inc. | MCKENZIE W THORPE | Director | Option Exercise | M | 13.26 | 50,000 | 663,000 | 50,000 | |
| Sep 16 2016 | XBIT | XBiotech Inc. | BONANNI FABRIZIO | Director | Option Exercise | M | 13.26 | 50,000 | 663,000 | 50,000 | |
| Sep 16 2016 | XBIT | XBiotech Inc. | VASELLA DANIEL | Director | Option Exercise | M | 13.26 | 50,000 | 663,000 | 50,000 | |
| Sep 12 2016 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Option Exercise | M | 0.77 | 427 | 329 | 19,573 | |
| Sep 12 2016 | XBIT | XBiotech Inc. | HAN QUEENA | VP Finance & HR | Sell | S | 15.00 | 427 | 6,405 | 0 | 427 to 0 (-100.00 %) |